« Back
An In Silico Test Battery for Rapid Evaluation of Genotoxic and Carcinogenic Potential of Chemicals
Poster Title: An In Silico Test Battery for Rapid Evaluation of Genotoxic and Carcinogenic Potential of Chemicals
Submitted on 23 Dec 2013
Author(s): Kiril Lanevskij, Liutauras Juska, Justas Dapkunas, Andrius Sazonovas, Pranas Japertas and Remigijus Didziapetris
Affiliations: Advanced Chemistry Development Inc
Poster Views: 1,613
View poster »

Poster Information

According to the FDA Guidance for Industry, impurities identified below the ICH qualification thresholds may be evaluated for genotoxicity and carcinogenicity based on structural activity relationship (SAR) assessments using computational software. This work is an extension of our previous study focusing on computational assessment of genotoxic impurities in drug products. Our new approach relies on a battery of probabilistic QSAR models supplemented by a knowledge-based expert system that identifies structural fragments, potentially responsible for hazardous activity. The analysis was based on experimental data obtained from FDA, and involved 21 endpoints corresponding to different mechanisms of toxic action: mutagenicity, clastogenicity, carcinogenicity, etc. Probabilistic models for most endpoints were derived using GALAS (Global, Adjusted Locally According to Similarity) modeling methodology developed in our group. The updated list of alerting groups contained 70 distinct substructures. The expert system was highly sensitive, recognizing >90% of potent carcinogens, as classified by the FDA. Sensitivity of probabilistic models ranged from about 60% to more than 90%, while maintaining high (>80%) specificity of predictions for the majority of considered assays. These results show that the described computational platform ensures sufficient prediction accuracy for rapid genotoxicity/ carcinogenicity profiling of various chemicals.
Summary: The FDA guidance for industry states impurities under the ICH threshold may be exaluated for genotoxicity and carcinogenicity. This study uses an expert system to detect mutagens and compounds labeled as potent carcinogens by the FDA.Report abuse »
Creative Commons

Related Posters

Parameters Estimation, Identifiability and Predictability Analysis in Systems Biology with HetaSimulator and LikelihoodProfiler
Ivan Borisov, Evgeny Metelkin

Heta language: Modularity and Reusability in QSP modeling platforms
Evgeny Metelkin

Genetic basis of the hornwort’s carbon-concentrating mechanism
Peter Szovenyi et al.

App Estadística básica

In silico identification and characterization of epitope-based peptide of Buffalo TLR4
Shipra Chauhan, Prashant Kumar, Prashant Singh, Anuradha Bhardwaj, Sanjay Kumar, Navneet Saxena, Dharmendra Kumar, Sajjan Singh, T.K.. Datta, Varij Nayan